Keyphrases
CE-ICP-MS
100%
Human Plasma
100%
Cisplatin Drug
100%
Metallomics
100%
Liposomal Cisplatin
100%
Drug Development
100%
Drug Formulation
100%
Cisplatin
100%
Liposome-encapsulated
27%
Liposomes
27%
PEGylated Liposomes
9%
Liposomal Formulation
9%
Liposomal Drugs
9%
Protein Binding
9%
Plasma Samples
9%
Limit of Detection
9%
Simultaneous Measurement
9%
Biomolecules
9%
Sodium Dodecyl Sulfate
9%
Mass Spectrometry Methods
9%
HEPES Buffer
9%
Inductively Coupled Plasma Mass Spectrometry
9%
Active Substances
9%
Capillary Electrophoresis
9%
Lipid-based Formulation
9%
Simultaneous Monitoring
9%
Plasma Matrix
9%
Plasma Constituents
9%
Material Science
Platinum
100%
Plasma (Human)
100%
Inductively Coupled Plasma Mass Spectrometry
50%
Capillary Electrophoresis
50%
Sodium Dodecyl Sulfate
50%